Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Hypertension (Dallas, Tex. : 1979)|September 16, 2000
Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that Is independent of cholesterol side-chain cleavageR I Dmitrieva, A Y Bagrov, E Lalli, et al.Life Sciences|June 1, 1999
Involvement of endogenous digitalis-like factors in voluntary selection of alcohol by ratsY Y Bagrov, N I Dmitrieva, N B Manusova, et al.American Journal of Hypertension|October 1, 1996
Endogenous marinobufagenin-like immunoreactive substance. A possible endogenous Na, K-ATPase inhibitor with vasoconstrictor activityA Y Bagrov, R I Dmitrieva, O V Fedorova, et al.Hypertension (Dallas, Tex. : 1979)|May 12, 1998
Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarctionA Y Bagrov, O V Fedorova, R I Dmitrieva, et al.Journal of Hypertension|August 31, 1999
Circulating bufodienolide and cardenolide sodium pump inhibitors in preeclampsiaD A Lopatin, E K Ailamazian, R I Dmitrieva, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 31, 2007
Endogenous Na/K-ATPase inhibitors in patients with preeclampsiaI V Averina, N I Tapilskaya, V A Reznik, et al.Journal of Hypertension|February 29, 2000
Cicletanine reverses vasoconstriction induced by the endogenous sodium pump ligand, marinobufagenin, via a protein kinase C dependent mechanismA Y Bagrov, R I Dmitrieva, N A Dorofeeva, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 31, 2007
Marinobufagenin in hypertensive patients with obstructive sleep apneaN E Zvartau, A O Conrady, Y V Sviryaev, et al.Pageof 3